GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 723 filers reported holding GLAXOSMITHKLINE PLC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $116,000 | +5.5% | 2,653 | +5.5% | 0.06% | +19.2% |
Q1 2022 | $110,000 | +175.0% | 2,515 | +176.4% | 0.05% | +173.7% |
Q4 2021 | $40,000 | -2.4% | 910 | -6.2% | 0.02% | -5.0% |
Q3 2021 | $41,000 | +5.1% | 970 | 0.0% | 0.02% | 0.0% |
Q2 2021 | $39,000 | +14.7% | 970 | 0.0% | 0.02% | +11.1% |
Q1 2021 | $34,000 | -5.6% | 970 | 0.0% | 0.02% | -18.2% |
Q4 2020 | $36,000 | -14.3% | 970 | -14.2% | 0.02% | -21.4% |
Q3 2020 | $42,000 | -6.7% | 1,130 | 0.0% | 0.03% | -6.7% |
Q2 2020 | $45,000 | +4.7% | 1,130 | 0.0% | 0.03% | -14.3% |
Q1 2020 | $43,000 | -46.9% | 1,130 | -34.9% | 0.04% | -34.0% |
Q4 2019 | $81,000 | +285.7% | 1,735 | +243.6% | 0.05% | +253.3% |
Q3 2019 | $21,000 | +31.2% | 505 | +26.2% | 0.02% | +36.4% |
Q2 2019 | $16,000 | 0.0% | 400 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $16,000 | +6.7% | 400 | 0.0% | 0.01% | -8.3% |
Q4 2018 | $15,000 | -6.2% | 400 | 0.0% | 0.01% | +9.1% |
Q3 2018 | $16,000 | 0.0% | 400 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $16,000 | 0.0% | 400 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $16,000 | -27.3% | 400 | -36.0% | 0.01% | -31.2% |
Q4 2017 | $22,000 | -18.5% | 625 | -7.4% | 0.02% | -23.8% |
Q3 2017 | $27,000 | -6.9% | 675 | 0.0% | 0.02% | -8.7% |
Q2 2017 | $29,000 | +26.1% | 675 | +22.7% | 0.02% | +43.8% |
Q1 2017 | $23,000 | +21.1% | 550 | +10.0% | 0.02% | +23.1% |
Q4 2016 | $19,000 | 0.0% | 500 | +11.1% | 0.01% | -7.1% |
Q3 2016 | $19,000 | +11.8% | 450 | +12.5% | 0.01% | +16.7% |
Q2 2016 | $17,000 | +6.2% | 400 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $16,000 | -5.9% | 400 | 0.0% | 0.01% | -7.7% |
Q4 2015 | $17,000 | +13.3% | 400 | 0.0% | 0.01% | +8.3% |
Q3 2015 | $15,000 | -11.8% | 400 | 0.0% | 0.01% | -7.7% |
Q2 2015 | $17,000 | -29.2% | 400 | -23.8% | 0.01% | -27.8% |
Q1 2015 | $24,000 | +41.2% | 525 | +31.2% | 0.02% | +38.5% |
Q4 2014 | $17,000 | -5.6% | 400 | 0.0% | 0.01% | -7.1% |
Q3 2014 | $18,000 | -14.3% | 400 | 0.0% | 0.01% | -12.5% |
Q2 2014 | $21,000 | 0.0% | 400 | 0.0% | 0.02% | -5.9% |
Q1 2014 | $21,000 | 0.0% | 400 | 0.0% | 0.02% | 0.0% |
Q4 2013 | $21,000 | +5.0% | 400 | 0.0% | 0.02% | -5.6% |
Q3 2013 | $20,000 | 0.0% | 400 | 0.0% | 0.02% | 0.0% |
Q2 2013 | $20,000 | – | 400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |